A 9-month-old intact crossbred female cat was presented with jaundice, intermittent anorexia and lethargy, increased hepatic enzyme activities, and hyperammonemia. Abdominal ultrasound and computed tomographic examinations determined that the liver had a rounded and irregular margin, and histopathological examination identified excessive accumulation of copper hepatocytes in the liver. Concentrations of both blood and urine copper were higher than in healthy cats. The patient responded well to treatment with penicillamine. Clinicopathological abnormalities and clinical signs improved within 2 months, and the patient was alive for >9 months after starting treatment. Genetic examination determined that the patient and its littermate had a single-nucleotide variation (SNV, p. T1297R) that impaired the function of the ATP7B gene product; the gene that is mutated in patients with Wilson's disease (WD). Hepatic copper accumulation was believed to be associated with the SNV of the ATP7B gene, and the patient had a genetic disorder of copper metabolism equivalent to WD in humans. The anti-feline infectious peritonitis virus antibody titer was <1:100.
A 9-month-old intact crossbred female cat was presented with jaundice, intermittent anorexia and lethargy, increased hepatic enzyme activities, and hyperammonemia. Abdominal ultrasound and computed tomographic examinations determined that the liver had a rounded and irregular margin, and histopathological examination identified excessive accumulation of copper hepatocytes in the liver. Concentrations of both blood and urine copper were higher than in healthy cats. The patient responded well to treatment with penicillamine. Clinicopathological abnormalities and clinical signs improved within 2 months, and the patient was alive for >9 months after starting treatment. Genetic examination determined that the patient and its littermate had a single-nucleotide variation (SNV, p. T1297R) that impaired the function of the ATP7B gene product; the gene that is mutated in patients with Wilson's disease (WD). Hepatic copper accumulation was believed to be associated with the SNV of the ATP7B gene, and the patient had a genetic disorder of copper metabolism equivalent to WD in humans. The anti-feline infectious peritonitis virus antibody titer was <1:100.
The patient was treated with lactulose (0.5 g PO q8h) and ursodeoxycholic acid (25 mg PO q24h). The owner fed the cat a general commercial diet without any supplements containing additional copper. One month previously, a 1-year-old intact crossbred male littermate from the same queen also was referred to VMC-UT with jaundice. The littermate was diagnosed with liver failure because of jaundice without bile duct obstruction, increased total bilirubin concentration (11.6 mg/dL; RR, 0.1-0.4 mg/dL), and hyperammonemia (139 μg/dL; RR, 23-78 μg/dL), and died 4 days after presentation.
On initial evaluation at VMC-UT, the cat weighed 2.3 kg and had a body condition score of 2/5; physical examination disclosed jaundice on oral mucous membrane examination. No abnormality was identified in the CBC, whereas results of blood biochemical tests identified increased Liver biopsy was performed using laparotomy for definitive diagnosis by histopathologic examination. Before liver biopsy, prothrombin time and activated partial thromboplastin time were confirmed to be within RRs, and the cat was treated with vitamin K 2 (menatetrenone, 0.9 mg/kg PO q48h) (Sannova Co., Gunma, Japan).
Biopsy specimens were fixed in 10% phosphate-buffered formalin, routinely processed, and embedded in paraffin. The liver had multiple regenerative nodules (Figure 2A and B), fibrosis, and inflammatory infiltration with neutrophils, macrophages, and plasma cells around the nodules ( Figure 2C ). The hepatocytes were swollen, and eosinophilic cytoplasmic granules were identified diffusely in hepatocytes Based on clinical data and age of onset, the cat was suspected to have primary copper-associated hepatopathy (PCH), which is similar to WD. Therefore, sequence analysis of the ATP7B and COMMD1
genes was conducted to investigate the cause of the hepatic copper accumulation. Mutations in the ATP7B gene have been known to cause WD, and the deletion of exon 2 of the COMMD1 gene has been reported in Bedlington Terriers, a well-characterized canine model of copper toxicosis. 2 Genomic DNA samples were extracted from the peripheral blood of the patient and the 10 healthy cats that were used for the measurement of blood and urine copper concentrations.
Twenty-four primer pairs and 3 primer pairs were synthesized to amplify the overlapping genomic DNA fragments spanning the coding region of the ATP7B (exon 1-21) and COMMD1 (exon 1-3) genes,
respectively (see Supporting Information). The DNA samples were FIGURE 3 Rhodanine staining of the cytoplasmic granules of the liver. A, The hepatocytes were swollen, and a number of eosinophilic cytoplasmic granules were observed (bar, 50 μm; HE). B, The granules were stained red to brown on rhodanine staining (bar, 50 μm) amplified using PCR, and the amplification was confirmed using electrophoresis. Nucleotide sequences were analyzed directly from the PCR products. Then, the specific mutations in the ATP7B and COMMD1 genes that were detected in the patient were extracted, and their impact on protein function was predicted using PolyPhen-2
(http://genetics.bwh.harvard.edu/pph2/) and PROVEAN (http:// provean.jcvi.org/seq_submit.php). This analysis also was conducted using a genomic DNA sample extracted from the peripheral blood of the patient's littermate described above.
Results of sequence analysis did not identify any mutations in the 
| DISCUSSION
Primary copper-associated hepatopathy in young cats has been reported in previous studies. [3] [4] [5] Cats with PCH present with nonspecific clinical signs, such as vomiting, anorexia, lethargy, and weight loss, and copper accumulation are detected mainly in the centrilobular regions of the liver. 4 However, the incidence of PCH is quite low, and there have been no investigations of genetic mutations in cats with PCH. The patient described here was <1 year old and diagnosed with hepatic cirrhosis with excessive copper accumulation in hepatocytes throughout the liver by histopathological examination. Based on the results of histological examination and the lack of history of excessive copper intake, the patient was suspected to have PCH. The difference in the distribution of copper accumulation between this patient and those of previous reports may be a consequence of the histological progression of PCH in this patient. One limitation of our report was that dry weight copper in the liver was not measured.
One of the best characterized PCH in dogs is autosomal recessive hepatic copper toxicosis in Bedlington Terriers, and deletion of exon 2 of the COMMD1 gene has been reported to cause PCH in some patients. 2 However, a genome wide association study recently identified SNVs in the ABCA12 gene (metal ion transporter) in Bedlington
Terriers without deletion of COMMD1 gene. 6 Long-Evans Cinnamon rat, 11 and Labrador Retrievers, [12] [13] [14] The patient responded well to the treatment and was alive >300 days after first presentation. This outcome is consistent with an observation in a previous report, which showed long-term survival of human patients with WD and cats with PCH that are treated with penicillamine. 4 In addition, blood copper concentration decreased and urine copper concentration increased after administration of penicillamine. These findings were consistent with those observed in human patients with WD. 15 Thus, these findings suggest that penicillamine can be effective in the treatment of cats with PCH, and blood and urine copper concentrations can be used as the markers of the response to treatment. However, the RRs of blood and urine copper concentrations have not been determined previously, and the number of healthy cats used in our study was small. Thus, further investigations using a larger number of healthy cats are needed to determine the RR of blood and urine copper concentrations in cats.
In conclusion, we identified a young cat with PCH that had SNVs in the ATP7B gene that were damaging to the function of the ATP7B 
